<code id='32CD660DF0'></code><style id='32CD660DF0'></style>
    • <acronym id='32CD660DF0'></acronym>
      <center id='32CD660DF0'><center id='32CD660DF0'><tfoot id='32CD660DF0'></tfoot></center><abbr id='32CD660DF0'><dir id='32CD660DF0'><tfoot id='32CD660DF0'></tfoot><noframes id='32CD660DF0'>

    • <optgroup id='32CD660DF0'><strike id='32CD660DF0'><sup id='32CD660DF0'></sup></strike><code id='32CD660DF0'></code></optgroup>
        1. <b id='32CD660DF0'><label id='32CD660DF0'><select id='32CD660DF0'><dt id='32CD660DF0'><span id='32CD660DF0'></span></dt></select></label></b><u id='32CD660DF0'></u>
          <i id='32CD660DF0'><strike id='32CD660DF0'><tt id='32CD660DF0'><pre id='32CD660DF0'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:61
          Cathy McMorris Rodgers -- health policy coverage from STAT
          Rep. Cathy McMorris Rodgers announced her plans to leave Congress at the end of 2024. Anna Moneymaker/Getty Images

          WASHINGTON — Rep. Cathy McMorris Rodgers, the chair of a crucial House committee that handles health care issues, plans to leave Congress at the end of the year, she announced Thursday.

          It will be a major shakeup for a panel already ravaged by Republican retirements. Reps. Michael Burgess (R-Texas), Larry Bucshon (R-Ind.), Jeff Duncan (R-S.C.), Debbie Lesko (R-Ariz.), Greg Pence (R-Ind.) and Kelly Armstrong (R-N.D.) are all leaving at the end of this Congress, too.

          advertisement

          Under McMorris Rodgers, the panel led the way for House passage of a health care price transparency package that included the first major proposal to equalize payment between hospital outpatient departments and physician offices.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Roche drug slashes death risk in early
          Roche drug slashes death risk in early

          Roche'sboothatthe2023ESMOconference.AndrewJoseph/STATMADRID—ARochedrugloweredtheriskofrecurrenceorde

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Roivant's CEO is a star, but biotech's black hole persists

          MollyFerguson/STATRoivantSciences’MattGlinemightbethisyear’sbestbiopharmaCEO,andotherthoughtsaboutMo